Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10035-2 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 | 10196499 | |
10062-3 | GSK1070916 | KIN001-216 | LSM-1062 | 46885626 | |
10510-1 | LY294002 | LY-294002 | 3973 | ||
10348-1 | Z-Leu-Leu-Norvalinal | MG-115 | LSM-6358 | 9868928 | |
10265-1 | Pevonedistat | MLN 4924; MLN-4924; MLN4924 | LSM-6263 | 16720766 | |
10281-1 | Vinorelbine | Navelbine | LSM-6302 | 5311497 | |
10097-3 | Erlotinib | OSI-774 | LSM-1097 | 176870 | |
10102-3 | Taxol | Paclitaxel | LSM-1102 | 441276 | |
10263-1 | LBH589 | Panobinostat | LSM-4284 | 57519507 | |
10243-1 | CGC-11047 | PG11047 | LSM-4266 | 476863 | |
10345-3 | Torkinib | PP242 | LSM-6357 | 57347681 | |
10235-2 | Everolimus | RAD001 | LSM-4258 | 53398658 | |
10052-3 | Sirolimus | Rapamycin | LSM-1052 | 5040 | |
10264-1 | Methotrexate | Rheumatrex; Trexall; Amethopterin; MTX | LSM-5690 | 126941 | |
10517-1 | Ro 32-0432 | RO-320432 | 127757 | ||
10260-1 | Ispinesib | SB-715992 | LSM-5732 | 6851740 | |
10189-2 | Bosutinib | SKI-606 | LSM-1190 | 5328940 | |
10282-1 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 | 5311 | |
10175-3 | Sunitinib | Sutent; SU11248 | LSM-42800 | 3086686 | |
10236-1 | 17-AAG | Tanespimycin | LSM-43239 | 151069 | |
10247-1 | Docetaxel | Taxotere | LSM-6360 | 148124 | |
10208-2 | JNK-IN-5A | TCS JNK 5a; KIN001-188 | LSM-1209 | 766949 | |
10507-1 | Disulfiram | Tetraethylthiuram disulfide; TETD | 3117 | ||
10516-1 | Ribavirin | Tribavirin | 37542 | ||
10223-2 | AG1478 | Tyrphostin | LSM-1224 | 2051 |